Thyrotoxicosis

Physicians who treat patients with hypothyroidism should opt for levothyroxine monotherapy in most patients, and when treating patients with Graves’ disease, radioactive iodine is the optimal treatment option, according to a summary of new National Institute for Health and Care Excellence, or NICE, guidelines published in The BMJ.

The overall standardized incidence rate of overt thyrotoxicosis in Denmark decreased by 50% after more than a decade of mandatory iodine fortification in the country without an increase in the overall incidence of sustained, overt hypothyroidism, according to findings published in Clinical Endocrinology.